-
Mashup Score: 15Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer - 1 month(s) ago
Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is defined by the presence of the estrogen receptor and/or the progesterone receptor and the …
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Acute myeloid leukemia management and research in 2025 - 1 month(s) ago
The first 5 decades of research in acute myeloid leukemia (AML) were dominated by the cytarabine plus anthracyclines backbone, with advances in strategies including allogeneic hematopoietic stem cell…
Categories: General Medicine News, Onc News and JournalsTweet-
Acute myeloid leukemia therapy has come a long way since being dominated by cytarabine and anthracyclines. @DrHKantarjian et al review the frontline and later line therapies in AML & discuss important research directions in this review. https://t.co/Vys7JCVfZF @OncoAlert #ASH24 https://t.co/lZIWY7sOps
-
-
Mashup Score: 27Breast cancer: The good, the bad, and an important call to effective risk reduction strategies - 1 month(s) ago
Click on the article title to read more.
Categories: General Medicine News, Oncologists1Tweet-
"As we celebrate overall improvements in breast cancer survival, mortality rates in Black women remain unchanged." Read a new editorial from @VKaklamani and @CarlosArteagaMD: https://t.co/HWDidvPcBQ @OncoAlert @AhJemal @Jess_S_Research #BreastCancerAwarenessMonth https://t.co/qrJqUPPpK7
-
-
Mashup Score: 27Breast cancer: The good, the bad, and an important call to effective risk reduction strategies - 1 month(s) ago
Click on the article title to read more.
Categories: General Medicine News, Oncologists1Tweet-
"As we celebrate overall improvements in breast cancer survival, mortality rates in Black women remain unchanged." Read a new editorial from @VKaklamani and @CarlosArteagaMD: https://t.co/HWDidvPcBQ @OncoAlert @AhJemal @Jess_S_Research #BreastCancerAwarenessMonth https://t.co/qrJqUPPpK7
-
-
Mashup Score: 16
Sexual function is a vital aspect of quality of life among adolescent and young adult (AYA) (ages 15-39 years) cancer survivors. Sexual function encompasses physical, psychosocial, and developmental …
Categories: General Medicine News, Oncologists1Tweet-
CA EIC Don Dizon speaks today at 12pm at #SABCS24 on sexuality after a cancer diagnosis. Interventions supporting sexual health and psychosexual adjustment after treatment are needed. See review on sexual health among AYA cancer survivors: https://t.co/uWwqp1rVwD @OncoAlert https://t.co/fc5g2NDs8K
-
-
Mashup Score: 6
In the United States, over 2 million individuals openly identify with a gender that differs from their sex assigned at birth. A cancer diagnosis is physically and psychologically taxing—and, in some,…
Categories: General Medicine News, Oncologists1Tweet-
Over 2M people in the US identify with a gender differing from their sex at birth. This new @CancerCareMASCC review offers practical recommendations for delivering quality cancer care to transgender & gender-diverse people. https://t.co/Q921oNaIDy @CathcartRake @OncoAlert https://t.co/SJflTD0BLJ
-
-
Mashup Score: 8A review of cancer immunotherapy toxicity - 1 month(s) ago
Cancer immunotherapies, including checkpoint inhibitors and adoptive cell therapy, manipulate the immune system to recognize and attack cancer cells. These therapies have the potential to induce dura…
Categories: General Medicine News, Oncologists1Tweet-
A review of cancer immunotherapy toxicity by @DukeCancer authors Lucy Boyce Kennedy and April K.S. Salama focuses on the toxicities of checkpoint inhibitors & chimeric antigen receptor T cells, including pathophysiology, diagnosis, and management. #ASH24 https://t.co/V1lNPpTPQg https://t.co/gTuOXwNJRO
-
-
Mashup Score: 4Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice - 2 month(s) ago
Multiple myeloma (MM) is a hematologic malignancy defined by the clonal proliferation of transformed plasma cells. Despite tremendous advances in the treatment paradigm of MM, a cure remains elusive …
Categories: General Medicine News, Onc News and JournalsTweet-
This #OpenAcess review describes the strategies to overcome therapeutic challenges of CAR T cells in the hope of achieving a cure for multiple myeloma. https://t.co/TMjCzOg0zy https://t.co/EYsMuc3Nrv
-
-
Mashup Score: 6The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future - 2 month(s) ago
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Categories: General Medicine News, Onc News and JournalsTweet-
Effective multimodal treatment options for patients w/ peritoneal metastasis arise from better systemic therapy combinations, cytoreductive surgery, and rigorous investigation of combining regional therapy. https://t.co/V3dW0fvAeX https://t.co/RUVjiHaDCc
-
-
Mashup Score: 12
Cancer has myriad effects on metabolism that include both rewiring of intracellular metabolism to enable cancer cells to proliferate inappropriately and adapt to the tumor microenvironment, and chang…
Categories: General Medicine News, Oncologists1Tweet-
Metabolomics has emerged as a powerful tool in cancer research and treatment, with the potential to impact core areas of oncology, including screening, diagnosis, and therapy. Revisit our #OpenAccess review of this rising field of study: https://t.co/aCBgToQWF5 @LocasaleLab https://t.co/5FI8XNOi1L
-
#SABCS24 is a great time to reread the comprehensive #OpenAccess review from @laura_huppert, Ozge Gumusay, @Idossa_MD, & @hoperugo as they discuss the treatment landscape in HR+/HER2- #BreastCancer. 🔗 https://t.co/TS4avPKUyI @OncoAlert https://t.co/s3sN5yABDY